Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Voss Value Fund's investment thesis on Cellebrite ($CLBT) — Q3 2025 | Buyside Digest

$CLBTNASDAQCellebrite

BULL

Voss Value Fund—CLBT

Fund Letter

Q3 2025

Published November 25, 2025

$15.44USD

+34.8% vs last month

$16.86Pitched

-8.4% since pitch

Market Cap$3.9B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

In Q3 2025, Voss Value Fund, LP returned +5.0% net of fees, underperforming key benchmarks (Russell 2000 +12.4%, S&P 500 +8.3%). The fund has...

— Travis Cocke

BSD Research Exclusive

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

Other investors who've written on Cellebrite

No other institutional pitches found for this ticker yet.